WCN26-5760 MINERALOCORTICOID ANTAGONISTS INHIBT THE PROFIBROTIC EFFECTS OF THE ENDOGENOUS CARDIOTONIC STEROID MARINOBUFAGENIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Read full text Summarise with VIRAT
Authors: Mai Ots-Rosenberg, Kaja Metsküla, Anne Grethe Tuisk, Anne Kuudeberg, Alexei Y. Bagrov
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Endogenous digitalis-like cardiotonic steroids (CTS), i.e., inhibitors of Na and K-ATPase, were first considered important in the regulation of renal sodium transport and arterial pressure. Recent studies have implicated CTS in cell growth and fibrosis and in the pathogenesis of chronic kidney disease (CKD). Marinobufagenin (MBG) is a CTS that induces fibrosis through a mechanism involving Fli1, a negative regulator of collagen-1 synthesis, in accordance with our previous studies in rats with subtotal nephrectomy and preeclampsia.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Hormonal Regulation and Hypertension Cardiac Fibrosis and Remodeling

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105385–105385
Publication date
25 March 2026
Language
EN